Ardelyx (ARDX) Amortization of Deferred Charges (2015 - 2022)

Ardelyx (ARDX) reported Amortization of Deferred Charges of $179000.0 for Q2 2022, up 163.24% on a YoY basis from $68000.0 in Q2 2021, and up 280.85% quarter-over-quarter from $47000.0 in Q1 2022.

Ardelyx (ARDX) Amortization of Deferred Charges (2015 - 2022) Analysis & Trends

Ardelyx has reported Amortization of Deferred Charges for 8 years, with the latest figure at $179000.0 in Q2 2022.

  • For the quarter ending Q2 2022, Amortization of Deferred Charges rose 163.24% year-over-year to $179000.0; the trailing twelve-month figure through Jun 2022 stood at $321000.0 (down 10.58% YoY), and the FY2021 full-year result was $240000.0, down 51.61% from the prior year.
  • Amortization of Deferred Charges for Q2 2022 stood at $179000.0, up from $47000.0 in the prior quarter.
  • The five-year high for Amortization of Deferred Charges was $396000.0 in Q3 2019, with the low at -$241000.0 in Q4 2019.
  • Historically, Amortization of Deferred Charges has averaged $83722.2 across 5 years, with a median of $77500.0 in 2019.
  • Annual changes were most pronounced in 2019 — Amortization of Deferred Charges plunged 361.96% — and 2021, when it soared 806.38%.
  • Ardelyx's Amortization of Deferred Charges stood at $92000.0 in 2018, then sank by 361.96% to -$241000.0 in 2019, then soared by 208.3% to $261000.0 in 2020, then plunged by 190.8% to -$237000.0 in 2021, then surged by 175.53% to $179000.0 in 2022.
  • The last three Amortization of Deferred Charges figures came in at $179000.0 (Q2 2022), $47000.0 (Q1 2022), and -$237000.0 (Q4 2021), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Ardelyx 1.49 Bn 1.25 Bn 89.66 Mn

Historic Data

Download Data
DateValue
Jun 30, 2022 179,000.00
Jun 30, 2022 179,000.00
Mar 31, 2022 47,000.00
Mar 31, 2022 47,000.00
Dec 31, 2021 -237,000.00
Dec 31, 2021 -237,000.00
Sep 30, 2021 332,000.00
Sep 30, 2021 332,000.00
Jun 30, 2021 68,000.00
Jun 30, 2021 68,000.00
Mar 31, 2021 77,000.00
Mar 31, 2021 77,000.00
Dec 31, 2020 261,000.00
Dec 31, 2020 261,000.00
Sep 30, 2020 -47,000.00
Sep 30, 2020 -47,000.00
Jun 30, 2020 170,000.00
Jun 30, 2020 170,000.00
Mar 31, 2020 112,000.00
Mar 31, 2020 112,000.00